Agreed. Until we get some OFFICIAL PR or shareholder letter from arrayit management, we are left in the dark. Their twitter feed is just name drops of other biotech companies and deals they have in place but no hard data on debt consolidation, plans for managing share structure, UPDATES ON FDA APPROVALS with OvaDX...it's frustrating. Everything here is pretty much speculation until we get some updated news from Arrayit Management